Variant report
Variant | nsv508472 |
---|---|
Chromosome Location | chr7:96474696-96491567 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BACH1 | chr7:96486956-96487015 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr7:96489541-96489582 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr7:96485085-96485322 | HepG2 | liver: | n/a | chr7:96485207-96485218 |
4 | CTCF | chr7:96490360-96490510 | BE2_C | brain: | n/a | n/a |
5 | CTCF | chr7:96489473-96489541 | GM13977 | blood: | n/a | n/a |
6 | FOXA2 | chr7:96481341-96481882 | A549 | lung: | n/a | n/a |
7 | FOXA2 | chr7:96484012-96484248 | HepG2 | liver: | n/a | n/a |
8 | FOXA2 | chr7:96481379-96481708 | A549 | lung: | n/a | n/a |
9 | MAFK | chr7:96485242-96485280 | HepG2 | liver: | n/a | n/a |
10 | POLR2A | chr7:96488760-96488805 | A549 | lung: | n/a | n/a |
11 | REST | chr7:96490626-96490768 | Hela-S3 | cervix: | n/a | n/a |
12 | SPI1 | chr7:96477688-96478172 | GM12878 | blood: | n/a | n/a |
13 | TAF7 | chr7:96484167-96484316 | K562 | blood: | n/a | n/a |
14 | TBP | chr7:96484239-96484409 | K562 | blood: | n/a | n/a |
15 | TCF7L2 | chr7:96484295-96484856 | HEK293 | kidney: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:96483662-96483712 | Hepatocyte | liver: | n/a |
2 | chr7:96483662-96483712 | HepG2 | liver: | n/a |
3 | chr7:96483662-96483712 | BE2_C | brain: | n/a |
4 | chr7:96483662-96483712 | HNPCEpiC | eye: | n/a |
5 | chr7:96483662-96483712 | AG09319 | gingival: | n/a |
6 | chr7:96483662-96483712 | PANC-1 | pancreas: | n/a |
7 | chr7:96483662-96483712 | NHBE | bronchial: | n/a |
8 | chr7:96483662-96483712 | HRPEpiC | eye: | n/a |
9 | chr7:96483662-96483712 | ProgFib | skin: | n/a |
10 | chr7:96483662-96483712 | H1-hESC | embryonic stem cell: | embryo |
11 | chr7:96483662-96483712 | HCM | heart: | n/a |
12 | chr7:96483662-96483712 | LNCaP | prostate: | n/a |
13 | chr7:96483662-96483712 | SK-N-MC | brain: | n/a |
14 | chr7:96483662-96483712 | U87 | brain: | n/a |
15 | chr7:96483662-96483712 | HPAEpiC | pulmonary alveolar: | n/a |
16 | chr7:96483662-96483712 | NT2-D1 | testis: | n/a |
17 | chr7:96483662-96483712 | SK-N-SH | brain: | n/a |
18 | chr7:96483662-96483712 | GM19239 | blood: | n/a |
19 | chr7:96483662-96483712 | GM12892 | blood: | n/a |
20 | chr7:96483662-96483712 | BJ | skin: | n/a |
21 | chr7:96483662-96483712 | HEEpiC | esophagus: | n/a |
22 | chr7:96483662-96483712 | ovcar-3 | ovarian: | n/a |
23 | chr7:96483662-96483712 | NH-A | brain: | n/a |
24 | chr7:96483662-96483712 | PrEC | prostate: | n/a |
25 | chr7:96483662-96483712 | T-47D | breast: | n/a |
26 | chr7:96483662-96483712 | K562 | blood: | n/a |
27 | chr7:96483662-96483712 | CMK | blood: | n/a |
28 | chr7:96483662-96483712 | AG09309 | skin: | n/a |
29 | chr7:96483662-96483712 | HIPEpiC | eye: | n/a |
30 | chr7:96483662-96483712 | SAEC | small airway: | n/a |
31 | chr7:96483662-96483712 | PFSK-1 | brain: | n/a |
32 | chr7:96483662-96483712 | NB4 | blood: | n/a |
33 | chr7:96483662-96483712 | HCT-116 | colon: | n/a |
34 | chr7:96483662-96483712 | MCF10A-Er-Src | breast: | n/a |
35 | chr7:96483662-96483712 | SKMC | muscle: | n/a |
36 | chr7:96483662-96483712 | A549 | lung: | n/a |
37 | chr7:96483662-96483712 | HCPEpiC | choroid plexus: | n/a |
38 | chr7:96483662-96483712 | ECC-1 | luminal epithelium: | n/a |
39 | chr7:96483662-96483712 | AoSMC | blood vessel: | n/a |
40 | chr7:96483662-96483712 | MCF-7 | breast: | n/a |
41 | chr7:96483662-96483712 | HUVEC | blood vessel: | n/a |
42 | chr7:96483662-96483712 | SK-N-SH_RA | brain: | n/a |
43 | chr7:96483662-96483712 | NHDF-neo | bronchial: | n/a |
44 | chr7:96483662-96483712 | Caco-2 | colon: | n/a |
45 | chr7:96483662-96483712 | HCF | heart: | n/a |
46 | chr7:96483662-96483712 | Hela-S3 | cervix: | n/a |
47 | chr7:96483662-96483712 | AG04449 | skin: | fetal |
48 | chr7:96483662-96483712 | Jurkat | blood: | n/a |
49 | chr7:96483662-96483712 | HRCEpiC | kidney: | n/a |
50 | chr7:96483662-96483712 | HMEC | breast: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MARK2P10 | TF binding region |
MARK2P10 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145566396 | chr7:96484036-96484037 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs148470769 | chr7:96484053-96484054 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs545538488 | chr7:96484098-96484099 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs60799465 | chr7:96484113-96484114 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs565488870 | chr7:96484118-96484119 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs531227888 | chr7:96484121-96484122 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186722588 | chr7:96484123-96484124 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs567300107 | chr7:96484138-96484139 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs146999451 | chr7:96484159-96484160 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs546698693 | chr7:96484167-96484168 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs147662054 | chr7:96484190-96484191 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs538455780 | chr7:96484224-96484225 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs538502839 | chr7:96484231-96484232 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs558706568 | chr7:96484275-96484276 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs569089487 | chr7:96484289-96484290 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs376033995 | chr7:96484290-96484291 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs538118424 | chr7:96484293-96484294 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs540943143 | chr7:96484357-96484358 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs189501934 | chr7:96484358-96484359 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs181181585 | chr7:96484492-96484493 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs540198269 | chr7:96484499-96484500 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs553909689 | chr7:96484561-96484562 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs367756368 | chr7:96484573-96484574 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs186021398 | chr7:96484586-96484587 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs1522527 | chr7:96484605-96484606 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs189690392 | chr7:96484629-96484630 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs561106796 | chr7:96484648-96484649 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs544526593 | chr7:96484658-96484659 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs183381552 | chr7:96484702-96484703 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs7785299 | chr7:96484741-96484742 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs146396857 | chr7:96484744-96484745 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs562278305 | chr7:96484787-96484788 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs554234334 | chr7:96484852-96484853 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs367908040 | chr7:96484856-96484857 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs566663353 | chr7:96484885-96484886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532621252 | chr7:96484898-96484899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7456227 | chr7:96484929-96484930 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs569052250 | chr7:96484933-96484934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186438906 | chr7:96484971-96484972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558832332 | chr7:96484978-96484979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554914465 | chr7:96484984-96484985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375664043 | chr7:96485005-96485006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78019226 | chr7:96485046-96485047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533820180 | chr7:96485116-96485117 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs2894073 | chr7:96485117-96485118 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs576900226 | chr7:96485141-96485142 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs190808410 | chr7:96485167-96485168 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs555957803 | chr7:96485209-96485210 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs375254594 | chr7:96485230-96485231 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs113531265 | chr7:96485246-96485247 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Schizophrenia | 17879154 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 20858243 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Myoclonus-dystonia | 17898012 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164920 | CNVD |
abnormal development | 18461090 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:96484000-96484800 | Enhancers | HepG2 | liver |
2 | chr7:96484000-96485200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr7:96484400-96485400 | Enhancers | Adipose Nuclei | Adipose |
4 | chr7:96484600-96485000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr7:96484600-96485800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |